Feb 19, 2018 – St. Louis-based Unleash Immuno Oncolytics Attracts $3 Million Investment from Publicly-traded Japanese Company
St. Louis-based Unleash Immuno Oncolytics Attracts $3 Million Investment from Publicly-traded Japanese Company BioGenerator-supported Company to Advance Cancer Therapies ST. LOUIS – St. Louis-based startup… Read More »Feb 19, 2018 – St. Louis-based Unleash Immuno Oncolytics Attracts $3 Million Investment from Publicly-traded Japanese Company